REG - Haleon PLC - Results of Haleon 2026 Annual General Meeting

HALEONAnnouncement

29/04/2026 17:01

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260429:nRSc4592Ca&default-theme=true

RNS Number : 4592C  Haleon PLC  29 April 2026

Haleon plc: Results of Haleon 2026 Annual General Meeting

 

29 April 2026: Haleon plc (the "Company" or "Haleon) (LSE/NYSE: HLN) announces
that the following resolutions were decided by poll vote at the Company's 2026
Annual General Meeting ("AGM") which was held today.

 

Resolutions 20, 21, 22 and 23 were passed as special resolutions; all other
resolutions were passed as ordinary resolutions. Full text of the resolutions
is contained in the Company's Notice of 2026 AGM, which is available at
www.haleon.com (http://www.haleon.com) .

 

Haleon plc - Poll Results

 

 Resolution                                                                             Votes for      For (% of shares voted)  Votes against  Against (% of shares voted)  Total votes cast (excluding withheld)  % of issued share capital voted(1)  Votes withheld(2)
 1       To receive the Annual Report & Accounts                                        7,518,381,689  99.99                    974,818        0.01                         7,519,356,507                          84.57%                              41,371,913
 2       To approve the Directors' Remuneration Report                                  7,385,589,576  98.00                    151,074,594    2.00                         7,536,664,170                          84.77%                              24,063,940
 3       To approve the Directors' Remuneration Policy                                  7,133,534,799  94.65                    402,883,378    5.35                         7,536,418,177                          84.76%                              24,310,243
 4       To declare a final dividend                                                    7,540,340,495  99.99                    1,088,307      0.01                         7,541,428,802                          84.82%                              19,299,618
 5       To re-elect Manvinder Singh (Vindi) Banga                                      7,508,532,595  99.57                    32,203,620     0.43                         7,540,736,215                          84.81%                              19,991,895
 6       To re-elect Brian McNamara                                                     7,506,462,082  99.54                    34,382,494     0.46                         7,540,844,576                          84.81%                              19,883,534
 7       To re-elect Dawn Allen                                                         7,464,666,016  98.99                    76,193,454     1.01                         7,540,859,470                          84.81%                              19,868,950
 8       To re-elect Alan Stewart                                                       7,523,725,090  99.77                    17,312,615     0.23                         7,541,037,705                          84.82%                              19,690,715
 9       To re-elect Nancy Avila                                                        7,527,476,825  99.83                    13,173,973     0.17                         7,540,650,798                          84.81%                              20,077,622
 10      To re-elect Marie-Anne Aymerich                                                7,514,059,525  99.84                    11,924,672     0.16                         7,525,984,197                          84.65%                              34,743,913
 11      To re-elect Bláthnaid Bergin                                                   7,535,655,488  99.93                    5,031,351      0.07                         7,540,686,839                          84.81%                              20,041,582
 12      To re-elect Tracy Clarke                                                       7,496,699,209  99.41                    44,348,201     0.59                         7,541,047,410                          84.82%                              19,677,335
 13      To re-elect Dame Vivienne Cox                                                  7,517,554,491  99.69                    23,507,481     0.31                         7,541,061,972                          84.82%                              19,666,449
 14      To re-elect Asmita Dubey                                                       7,536,859,688  99.95                    3,756,869      0.05                         7,540,616,557                          84.81%                              20,111,863
 15      To elect Matthew Shattock                                                      7,537,243,742  99.96                    3,237,791      0.04                         7,540,481,533                          84.81%                              20,246,887
 16      To re-appoint KPMG as auditor of the Company                                   7,539,941,050  99.98                    1,220,592      0.02                         7,541,161,642                          84.82%                              19,561,576
 17      To authorise the Audit & Risk Committee to set the auditor's remuneration      7,539,239,644  99.98                    1,669,241      0.02                         7,540,908,885                          84.81%                              19,819,535
 18      To authorise the Company to make political donations                           7,438,001,218  99.00                    75,178,085     1.00                         7,513,179,303                          84.50%                              47,549,118
 19      To authorise the Directors to allot ordinary shares                            7,248,168,508  96.12                    292,273,298    3.88                         7,540,441,806                          84.81%                              20,286,615
 20      General authority to disapply pre-emption rights                               7,177,724,786  95.20                    361,654,667    4.80                         7,539,379,453                          84.80%                              21,348,967
 21      Additional authority to disapply pre-emption rights                            6,995,143,055  92.78                    544,236,758    7.22                         7,539,379,813                          84.80%                              21,348,334
 22      To authorise a 14-day notice period for general meetings                       7,054,966,644  93.56                    485,779,174    6.44                         7,540,745,818                          84.81%                              19,982,603
 23      To authorise the Company to purchase its own shares                            7,533,340,747  99.93                    5,392,478      0.07                         7,538,733,225                          84.79%                              21,991,442

 

(1) For the purposes of section 341 of the Companies Act 2006, as at 6:30pm
(BST) on Friday, 24 April 2026, Haleon's issued share capital was
8,903,405,354 ordinary shares of £0.01 each, 12,281,053 of which were held as
treasury shares. Therefore, the total voting rights in the Company were
8,891,124,301.

(2) A "Vote withheld" is not a vote in law and is not counted in the
calculation of the votes "For" or "Against" a resolution.

 

As required by the UK Listing Rule 6.4.2R of the Financial Conduct Authority
("FCA"), copies of resolutions passed by the Company other than resolutions
concerning ordinary business have been submitted to the FCA via the National
Storage Mechanism and will shortly be available to the public for inspection
at https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism) .

 

 

Amanda Mellor

Company Secretary

 

About Haleon

Haleon (LSE/NYSE: HLN) is a consumer company that is solely focused on better
everyday health. Our people, our brands, our research, our investment and our
innovation are aimed at improving the everyday health of consumers. Our
product portfolio spans six major categories - Oral Health, Vitamins, Minerals
and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and
Therapeutic Skin Health and Other. Our superior brands - such as Advil,
Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and
Voltaren - are trusted by more than one billion consumers and are recommended
by health professionals around the world.

 

For more information, please visit www.haleon.com (http://www.haleon.com/)
.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RAGEKLFLQZLZBBZ



            Copyright 2019 Regulatory News Service, all rights reserved